| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.47 | 0.004 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.005 |